These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11501600)

  • 1. Therapies on the horizon for cholesterol reduction.
    Brown WV
    Clin Cardiol; 2001 Aug; 24(8 Suppl):III24-7. PubMed ID: 11501600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to lipid lowering: what is on the horizon?
    Brown WV
    Am J Cardiol; 2001 Mar; 87(5A):23B-27B. PubMed ID: 11256846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer pharmaceutical agents to treat lipid disorders.
    Davidson MH
    Curr Cardiol Rep; 2003 Nov; 5(6):463-9. PubMed ID: 14558988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in lipid-modifying therapies for reducing cardiovascular risk.
    Bruckert E
    Cardiology; 2002; 97(2):59-66. PubMed ID: 11978950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.
    Viigimaa M; Vaverkova H; Farnier M; Averna M; Missault L; Hanson ME; Dong Q; Shah A; Brudi P
    Lipids Health Dis; 2010 Nov; 9():127. PubMed ID: 21050476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of a Sardinian patient affected by Autosomal Recessive Hypercholesterolemia (ARH).
    Muntoni S; Pisciotta L; Muntoni S; Bertolini S
    J Clin Lipidol; 2015; 9(1):103-6. PubMed ID: 25670367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Oct; 22(10):2037-9. PubMed ID: 17022863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
    Bays HE; Davidson MH; Massaad R; Flaim D; Lowe RS; Tershakovec AM; Jones-Burton C
    Am J Cardiol; 2011 Aug; 108(4):523-30. PubMed ID: 21596364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.
    Ason B; Tep S; Davis HR; Xu Y; Tetzloff G; Galinski B; Soriano F; Dubinina N; Zhu L; Stefanni A; Wong KK; Tadin-Strapps M; Bartz SR; Hubbard B; Ranalletta M; Sachs AB; Flanagan WM; Strack A; Kuklin NA
    J Lipid Res; 2011 Apr; 52(4):679-87. PubMed ID: 21262787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.
    Ballantyne CM; Miller E; Chitra R
    Clin Ther; 2004 Nov; 26(11):1855-64. PubMed ID: 15639697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future direction of cholesterol-lowering therapy.
    Evans M; Roberts A; Rees A
    Curr Opin Lipidol; 2002 Dec; 13(6):663-9. PubMed ID: 12441891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Ju SH; Lim JY; Song M; Kim JM; Kang YE; Yi HS; Joung KH; Lee JH; Kim HJ; Ku BJ
    Front Endocrinol (Lausanne); 2024; 15():1336357. PubMed ID: 38586464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.
    Rizzo M; Rini GB; Berneis K
    Adv Ther; 2007; 24(3):575-82. PubMed ID: 17660166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
    Robinson JG; Nedergaard BS; Rogers WJ; Fialkow J; Neutel JM; Ramstad D; Somaratne R; Legg JC; Nelson P; Scott R; Wasserman SM; Weiss R;
    JAMA; 2014 May; 311(18):1870-82. PubMed ID: 24825642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.